Science & Technology
A Novel Device for Uterine Hemostasis Post Cesarean Section
Department of Health and Human Services — National Institutes of Health
Opportunity #: 1R43HL174372-01A1
Award Ceiling
$309K
Award Floor
$309K
Close Date
Feb 28, 2025
Total Funding
$309K
Expected Awards
1
Posted Date
Sep 1, 2024
Cost Sharing Required
No
Grants.gov ID
sbir-1R43HL174372-01A1
Description
SBIR Phase Phase I award: "A Novel Device for Uterine Hemostasis Post Cesarean Section" awarded to Lucie Medical Inc in Spartanburg, South Carolina. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $308,526. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses, Women-owned businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.